Search Results 161-170 of 16497 for HMB loading phase

1. Lu AF82422 in participants with Multiple System Atrophy - Mayo Clinic

   In the later phase (phase 3), researchers study whether the treatment works ... There are also less common very early (phase 0) and later (phase 4) phases.

2. Study of SC-003 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer - Mayo Clinic

   The purpose of this Phase 1a/1b study of SC-003 in patients with platinum-resistant/refractory ovarian cancer is to characterize the safety and tolerability of ...

3. Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer - Mayo Clinic

   About this study. This randomized phase II/III trial studies how well paclitaxel, carboplatin, and metformin hydrochloride works and compares it to ...

4. A Study to Evaluate Chemoradiotherapy with or without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer - Mayo Clinic

   There are also less common very early (phase 0) and later (phase 4) phases. ... A CD4 count above 250 cells/mcL and an undetectable HIV viral load on standard PCR ...

5. Hematology - Clinical trials

   Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients ...

6. A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)] - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

7. Nonalcoholic fatty liver disease - Stages - Mayo Clinic

   Fibrosis staging is the most important factor in determining survival rates and prognosis. These stages are: F0: No scarring. F1: Mild scarring.

8. Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D) - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

9. Lenalidomide for Myelodysplastic Syndrome Refractory to Hypomethylating Agents - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

10. Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma (KarMMa) - Mayo Clinic

    In the later phase (phase ... There are also less common very early (phase 0) and later (phase 4) phases. ... load and be maintained on anti-viral therapy to ...